Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice
- PMID: 19940042
- PMCID: PMC2812077
- DOI: 10.1128/CVI.00305-09
Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice
Abstract
Long-term protection and antibody response for the subunit vaccine F1-rV270 were determined by using the mouse model. Antibodies to F1 and rV270 were still detectable over a period of 518 days. The complete protection against lethal challenge of Yersinia pestis could be achieved up to day 518 after primary immunization.
Figures
Similar articles
-
Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.Vaccine. 2010 Feb 10;28(6):1655-60. doi: 10.1016/j.vaccine.2009.02.078. Epub 2009 Mar 9. Vaccine. 2010. PMID: 20079562
-
Different strategies for preparation of non-tagged rV270 protein and its efficacy against Yersinia pestis challenge.Biomed Environ Sci. 2010 Oct;23(5):333-40. doi: 10.1016/S0895-3988(10)60073-6. Biomed Environ Sci. 2010. PMID: 21112480
-
rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli.Hum Vaccin Immunother. 2025 Dec;21(1):2507475. doi: 10.1080/21645515.2025.2507475. Epub 2025 May 26. Hum Vaccin Immunother. 2025. PMID: 40417828 Free PMC article.
-
Protecting against plague: towards a next-generation vaccine.Clin Exp Immunol. 2013 Apr;172(1):1-8. doi: 10.1111/cei.12044. Clin Exp Immunol. 2013. PMID: 23480179 Free PMC article. Review.
-
Prospects for new plague vaccines.Expert Rev Vaccines. 2009 Dec;8(12):1721-38. doi: 10.1586/erv.09.129. Expert Rev Vaccines. 2009. PMID: 19943765 Review.
Cited by
-
Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Clin Vaccine Immunol. 2015 Dec;22(12):1255-68. doi: 10.1128/CVI.00499-15. Epub 2015 Oct 7. Clin Vaccine Immunol. 2015. PMID: 26446423 Free PMC article.
-
Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.Clin Vaccine Immunol. 2012 Feb;19(2):228-34. doi: 10.1128/CVI.05559-11. Epub 2011 Dec 21. Clin Vaccine Immunol. 2012. PMID: 22190397 Free PMC article.
-
Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.mBio. 2021 Dec 21;12(6):e0322321. doi: 10.1128/mBio.03223-21. Epub 2021 Dec 7. mBio. 2021. PMID: 34872353 Free PMC article.
-
A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform.NPJ Vaccines. 2021 Jan 29;6(1):21. doi: 10.1038/s41541-020-00275-3. NPJ Vaccines. 2021. PMID: 33514747 Free PMC article.
-
Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine-Comparison of Immunoinformatic and Immunological Approaches.Vaccines (Basel). 2020 Nov 19;8(4):698. doi: 10.3390/vaccines8040698. Vaccines (Basel). 2020. PMID: 33228200 Free PMC article.
References
-
- Anderson, G. W., Jr., D. G. Heath, C. R. Bolt, S. L. Welkos, and A. M. Friedlander. 1998. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58:793-799. - PubMed
-
- Bourgeois, C., and C. Tanchot. 2003. CD4 T cells are required for CD8 T cell memory generation. Eur. J. Immunol. 33:3225-3231. - PubMed
-
- Campos, M., and D. L. Godson. 2003. The effectiveness and limitations of immune memory: understanding protective immune responses. Int. J. Parasitol. 33:655-661. - PubMed
-
- Glynn, A., L. C. Freytag, and J. D. Clements. 2005. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine 23:1957-1965. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical